Page 16 - Peter Bach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Pharmaceutical Care Management Association With Susannah Luthi, Brianna Ehley and Emily Martin On Tap — Biden hikes Medicare payments for Covid shots to get more providers on board. — CMS delays device rule, disappointing...

POLITICO Get the POLITICO Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by With David Lim Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need w...

MedCity News One year after founding, startup EQRx raises $500M to advance goal of cheaper cancer drugs The latest funding brings total investment in the company to $750 million. The money has gone, in part, toward licensing of promising drug candidates in breast, lung and other cancers. Shares1 A high-powered startup has raised $500 million toward its goal of making drugs for cancer and other chronic diseases more affordable and unveiled some of its most promising candidates. The company, Cambridge, Massachusetts-based EQRx, was co-founded last January by a prominent health policy expert a...

Order Reprints Print Article A pharmaceutical start-up that thinks it can undersell the entire drug industry got off to a quick start in its first year in business, grabbing rights to a handful of drugs, including two that could make it a player in the hottest cancer drug market sometime in the next few years. Now comes the hard part: Getting doctors to prescribe its cheap drugs, instead of brand-name competitors backed by big marketing budgets. On... Close A Start-Up That Wants to Undersell the Drug Industry Raises Another $500 Million A pharmaceutical start-up that thinks it can u...

Biden says he’ll tell the U.S. to stop holding back doses of the Covid-19 vaccine. The debate about holding back doses, explained. Vox.com 1/8/2021 Kelsey Piper © Tobias Schwarz/AFP via Getty Images In Berlin, people line up to get vaccinated against Covid-19. In the past couple of weeks, experts and pundits have debated a big question surrounding the rollout of the Covid-19 vaccines from Pfizer/BioNTech and Moderna: Do we stick to two doses for every person, spaced a couple of weeks apart, as was originally planned? Or should we go ahead and give out single doses to mo...